Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7362
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Transport, enzymatic activity, and stability of mutant sulfamidise (SGSH) identified in patients with mucopolysaccharidosis type III A
Author: Muschol, N.
Storch, S.
Balhausen, D.
Beesley, C.
Westermann, J.
Gal, A.
Ullrich, K.
Hopwood, J.
Winchester, B.
Braulke, T.
Citation: Human Mutation, 2004; 23(6):559-566
Publisher: Wiley-Liss
Issue Date: 2004
ISSN: 1059-7794
1098-1004
Statement of
Responsibility: 
Muschol, Nicole ; Storch, Stephan ; Ballhausen, Diana ; Beesley, Clare ; Westermann, Jan‐christoph ; Gal, Andreas ; Ullrich, Kurt ; Hopwood, John J. ; Winchester, Bryan ; Braulke, Thomas
Abstract: Mucopolysaccharidosis type IIIA (MPSIIIA) is an autosomal recessive lysosomal storage disease caused by mutations in the N-sulfoglucosamine sulfohydrolase gene (SGSH; encoding sulfamidase, also sulphamidase) leading to the lysosomal accumulation and urinary excretion of heparan sulfate. Considerable variation in the onset and severity of the clinical phenotype is observed. We report here on expression studies of four novel mutations: c.318C>A (p.Ser106Arg), c.488T>C (p.Leu163Pro), c.571G>A (p.Gly191Arg), and c.1207_1209delTAC (p.Tyr403del), and five previously known mutations: c.220C>T (p.Arg74Cys), c.697C>T (p.Arg233X), c.1297C>T (p.Arg433Trp), c.1026dupC (p.Leu343fsX158), and c.1135delG (p.Val379fsX33) identified in MPSIIIA patients. Transient expression of mutant sulfamidases in BHK or CHO cells revealed that all the mutants were enzymatically inactive with the exception of c.318C>A (p.Ser106Arg), which showed 3.3% activity of the expressed wild-type enzyme. Western blot analysis demonstrated that the amounts of expressed mutant sulfamidases were significantly reduced compared with cells expressing wild type. No polypeptides were immunodetectable in extracts of cells transfected with the cDNA carrying the c.697C>T (p.Arg233X) nonsense mutation. In vitro translation and pulse-chase experiments showed that rapid degradation rather than a decrease in synthesis is responsible for the low, steady-state level of the mutant proteins in cells. The amounts of secreted mutant precursor forms, the cellular stability, the proteolytic processing, and data from double-label immunofluorescence microscopy suggest that the degradation of the majority of newly synthesized c.220C>T (p.Arg74Cys), c.571G>A (p.Gly191Arg), c.1297C>T (p.Arg433Trp), c.1026dupC (p.Leu343fsX158), and c.1135delG (p.Val379fsX33) mutant proteins probably occurs in the ER, whereas c.488T>C (p.Leu163Pro) mutant protein showed instability in the lysosomes.
Keywords: Cell Line
CHO Cells
Lysosomes
Endoplasmic Reticulum
Animals
Humans
Mucopolysaccharidosis III
Hydrolases
Recombinant Proteins
Precipitin Tests
Enzyme Stability
Protein Biosynthesis
Protein Transport
Mutation
Molecular Sequence Data
Cricetinae
DOI: 10.1002/humu.20037
Published version: http://dx.doi.org/10.1002/humu.20037
Appears in Collections:Aurora harvest 5
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.